Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
154.43
+3.18 (2.10%)
At close: May 12, 2025, 4:00 PM
154.43
0.00 (0.00%)
After-hours: May 12, 2025, 4:39 PM EDT
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $9.32 billion as of May 12, 2025. Its market cap has increased by 12.84% in one year.
Market Cap
9.32B
Enterprise Value
9.68B
1-Year Change
12.84%
Ranking
Category
Stock Price
$154.43
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $9.32B, an increase of 1,977.42%. That is a compound annual growth rate of 34.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 9.18B | 15.89% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.30B |
| Johnson & Johnson | 372.70B |
| UnitedHealth Group | 343.89B |
| AbbVie | 338.11B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 230.98B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |